High vimentin expression is predictive of poorer survival in advanced stage epithelial ovarian cancer

被引：0
|
作者：
Full, Katherine [1 ]
Blansit, Kevin [2 ,3 ]
Lin, Nichole Young [3 ]
Fuh, Jen [1 ]
Yeaton-Massey, Amanda [1 ]
Longacre, Terry [1 ]
Owen, T. [1 ]
Chan, John K. [2 ,3 ]
机构：
[1] Stanford Univ, Sch Med, Stanford Canc Ctr, Dept Obstet & Gynecol,Div Gynecol Oncol, Stanford, CA 94305 USA
[2] Palo Alto Med Fdn, Res Inst, Palo Alto, CA USA
[3] Univ San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Obstet Gynecol & Reprod Sci, Div Gynecol Oncol, San Francisco, CA 94143 USA
来源：
GYNECOLOGIC ONCOLOGY | 2014年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.ygyno.2014.07.055
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：399 / 400
页数：2
相关论文
共 50 条
  • [1] Immune biomarkers are predictive of overall survival in advanced epithelial ovarian cancer
    Adams, Sarah F.
    Levine, Douglas A.
    Cadungog, Mark
    Zhang, Lin
    Hammond, Rachel
    Barakat, Richard
    Boyd, Jeff
    Gimotty, Phyllis
    Coukos, George
    GYNECOLOGIC ONCOLOGY, 2007, 104 (03) : S19 - S20
  • [2] Trends in therapy and survival of advanced stage epithelial ovarian cancer patients in the Netherlands
    van Altena, Anne M.
    Karim-Kos, Henrike E.
    de Vries, Esther
    Kruitwagen, Roy F. P. M.
    Massuger, Leon F. A. G.
    Kiemeney, Lambertus A.
    GYNECOLOGIC ONCOLOGY, 2012, 125 (03) : 649 - 654
  • [3] hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
    A Ercoli
    G Ferrandina
    G Raspaglio
    M Marone
    N Maggiano
    P Del Mastro
    P Benedetti Panici
    S Mancuso
    G Scambia
    British Journal of Cancer, 1999, 80 : 1665 - 1671
  • [4] hMSH2 and GTBP expression in advanced stage epithelial ovarian cancer
    Ercoli, A
    Ferrandina, G
    Raspaglio, G
    Marone, M
    Maggiano, N
    Del Mastro, P
    Panici, PB
    Mancuso, S
    Scambia, G
    BRITISH JOURNAL OF CANCER, 1999, 80 (10) : 1665 - 1671
  • [5] Advanced stage ovarian cancer survival in Jakarta
    Purbadi, Sigit
    Tanamas, Gregorius
    Novianti, Lisa
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (04) : 587 - 590
  • [6] Immune biomarkers predictive of survival in epithelial ovarian cancer
    Simons, E.
    Kiet, T.
    Amanam, I.
    Ho, M.
    Fuh, J.
    Fuh, K.
    Kapp, D.
    Odunsi, K.
    Chan, J.
    GYNECOLOGIC ONCOLOGY, 2012, 125 : S45 - S46
  • [7] Neoadjuvant chemotherapy in advanced stage epithelial ovarian cancer
    Kartsiounis, Christos
    Mitsakis, Ioannis
    Boutis, Anastasios
    Triantafillidis, Efstathios
    Evangelinos, Dimitrios
    Andreadis, Charalambos
    Kellartzis, Argirios
    ANNALS OF ONCOLOGY, 2006, 17 : 175 - 175
  • [8] Peritoneal cancer index as a predictor of survival in advanced stage serous epithelial ovarian cancer: a prospective study
    Elzarkaa, Alaa A.
    Shaalan, Waleed
    Elemam, Doaa
    Mansour, Hassan
    Melis, Mahmoud
    Malik, Eduard
    Soliman, Amr A.
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (04)
  • [9] Surgical and survival outcomes of advanced epithelial ovarian cancer
    Manie, Tamer Mostafa
    Shokralla, Hala Aziz
    Sheier, Sayed Shaker
    Fathalla, Ahmed El-Sayed
    MEDICAL SCIENCE, 2021, 25 (116) : 2477 - 2490
  • [10] Poorer survival in women with advanced ovarian cancer explains the UK's lower overall survival
    Mayor, Susan
    BRITISH MEDICAL JOURNAL, 2012, 345
12345